Ask AI
ProCE Banner Activity

Optimizing Molecular Profiling and Perioperative Management of Early-Stage NSCLC

Slideset

Download slides from a live webinar to gain global expert perspectives on molecular testing and perioperative immunotherapy and targeted therapy for early-stage NSCLC.

Released: May 15, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Lilly.

Lilly

Target Audience

This activity is intended for global medical oncologists, thoracic oncologists, pulmonologists, thoracic surgeons, pathologists, molecular biologists, and other healthcare professionals who care for patients with early-stage NSCLC.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Educate colleagues on the rationale and clinical utility of comprehensive molecular testing in early-stage NSCLC

  • Perform molecular testing in each patient with early-stage NSCLC consistent with current evidence and local expert guidance

  • Develop processes to optimize interdisciplinary communication and collaboration to ensure timely and accurate interpretation of molecular testing for each patient with early-stage NSCLC

  • Recommend the optimal targeted therapy or immunotherapy for each patient with early-stage NSCLC, considering molecular testing results, patient/disease factors, evidence, and local expert guidance

  • Appraise emerging evidence and ongoing clinical trials of novel targeted therapies and immunotherapies and the clinical implications for management of early-stage NSCLC